Rational drug design to explore the structure-activity relationship (SAR) of TRK inhibitors with 2,4-diaminopyrimidine scaffold
2012 ◽
pp. 539-558
Keyword(s):
1982 ◽
Vol 3
(3)
◽
pp. 255-265
◽
Keyword(s):
2011 ◽
Vol 82
(7)
◽
pp. 755-768
◽
Keyword(s):
2006 ◽
Vol 12
(35)
◽
pp. 4601-4611
◽
Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design
2009 ◽
Vol 30
(2)
◽
pp. 295-304
◽